Acute Exacerbations of COPD: Identification of Biological Clusters and Their Biomarkers.

Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., Lindblad, K., Patel, H., Rugman, P., Dodson, P., Jenkins, M., Saunders, M., Newbold, P., Green, R.H., Venge, P., Lomas, D.A., Barer, M.R., Johnston, S.L., Pavord, I.D., Brightling, C.E.
Journal   Am J Respir Crit Care Med.
Species  
Analytes Measured   Troponin I cardiac , Eotaxin-3 , GM-CSF , I-TAC , IL-10 , IL-13 , IL-4 , IL-5 , IL-6 , IL-6R , IL-8 , IP-10 , MCP-1 , MCP-4 , Myoglobin , RANTES , SAA , TARC , TNF-RI , TNF-RII
Matrix Tested   Serum and sputum
Year   2011
Volume  
Page Numbers  
Application   Cytokines and Chemokines
Abstract
Rationale Exacerbations of chronic obstructive pulmonary disease (COPD) are heterogeneous with respect to inflammation and etiology. Objectives Investigate biomarker expression in COPD exacerbations to identify biological clusters and determine biomarkers that recognise clinical COPD exacerbation phenotypes namely those associated with bacteria, viruses or eosinophilic airway inflammation. Methods Patients with COPD were observed for 1 year at stable and exacerbation visits. Biomarkers were measured in sputum and serum. Viruses and selected bacteria were assessed in sputum by polymerase chain reaction and routine diagnostic bacterial culture. Biological phenotypes were explored using unbiased cluster analysis and biomarkers that differentiated clinical exacerbation phenotypes were investigated. Measurements and Main Results 145 patients (101 men, 44 women) entered the study. 182 exacerbations were captured from 86 patients. Four distinct biological exacerbation clusters were identified. These were bacterial, viral or eosinophilic-predominant and a fourth was associated with limited changes in the inflammatory profile and was termed pauci-inflammatory. Of all exacerbations, 55%, 29% and 28% were associated with bacteria, virus and/or a sputum eosinophilia. The biomarkers that best identified these clinical phenotypes were sputum IL-1β (area under receiver-operator-characteristic-curve 0.89 (95% confidence interval 0.83 to 0.95), serum CXCL10 0.83 (0.70 to 0.96), and percentage peripheral eosinophils 0.85 (0.78 to 0.93) respectively. Conclusion The heterogeneity of the biological response of COPD exacerbations can be defined. Sputum IL-1β, serum CXCL10 and peripheral eosinophils are biomarkers of bacteria, virus or eosinophil associated exacerbations of COPD. Whether phenotype-specific biomarkers can be applied to direct therapy warrants further investigation.

View Publications

Related Products

U-PLEX Custom Immuno-Oncology Group 1 (hu) 384-well Assays
BAFF, BAFF-R/TNFRSF13C, BCMA/TNFRSF17, BDNF, CD20, CD27, CD28, CD40L (soluble), CD276/B7-H3, C-Peptide, CTACK, CTLA-4, ENA-78, Eotaxin, Eotaxin-2, Eotaxin-3, EPO, FGF (basic), FGF-23, FLT3L, Fractalkine, FSH, G-CSF, Ghrelin (active), Ghrelin (total), GIP (active), GIP (inactive), GIP (total), GITR/TNFRSF18, GITRL/TNFSF18, GLP-1 (active), GLP-1 (inactive), GM-CSF, gp130 (soluble), Granzyme A, Granzyme B, GRO-α, HAVCR2/TIM-3, I-309, IFN-α2a, IFN-β, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-2Rα, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17C, IL-17D, IL-17E/IL-25, IL-17F, IL-18, IL-21, IL-22, IL-23, IL-27, IL-29/IFN-λ1, IL-31, IL-33, Insulin, IP-10, I-TAC, LAG3, Leptin, Luteinizing Hormone (LH), MCP-1, MCP-2, MCP-4, M-CSF, MDC, MIF, MIP-1α, MIP-1β, MIP-5, OX40/TNFRSF4, PD1 (epitope 1), PD1 (epitope 2), PD-L1 (epitope 1), PD-L2, PlGF, PP, Proinsulin, PYY (total), RANKL/TNFSF11, SDF-1α, Tie-2, TIGIT, TLR1, TNF-α, TNF-β, TPO, TRAIL, TSLP, VEGF-A, VEGF-D, YKL-40 | Human
Multiplex
NEW
U-PLEX Custom Metabolic Group 1 (hu) 384-well Assays
BAFF, BDNF, β-NGF, C-Peptide, CTACK, ENA-78, Eotaxin, Eotaxin-2, Eotaxin-3, EPO, FGF-21, FGF-23, FLT3L, Fractalkine, FSH, G-CSF, Ghrelin (active), Ghrelin (total), GIP (active), GIP (inactive), GIP (total), GLP-1 (active), GLP-1 (inactive), GLP-1 (total), Glucagon, GM-CSF, GRO-α, I-309, IFN-α2a, IFN-β, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-2Rα, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17C, IL-17D, IL-17E/IL-25, IL-17F, IL-18, IL-21, IL-22, IL-23, IL-27, IL-29/IFN-λ1, IL-31, IL-33, Insulin, IP-10, Leptin, Luteinizing Hormone (LH), MCP-1, MCP-2, MCP-4, M-CSF, MDC, MIF, MIP-1α, MIP-5, PP, Proinsulin, PYY (total), SDF-1α, TARC, TNF-α, TNF-β, TPO, TRAIL, TSLP, VEGF-A, YKL-40 | Human
Multiplex
NEW
U-PLEX Biomarker Group 1 (hu) 384-well Assays
CTACK, ENA-78, Eotaxin, Eotaxin-2, Eotaxin-3, EPO, FLT3L, Fractalkine, G-CSF, GM-CSF, GRO-α, I-309, IFN-α2a, IFN-β, IL-1α, IL-1β, IL-1RA, IL-2, IL-2Rα, IL-3, IL-4, IL-6, IL-7, IL-9, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-17A, IL-17A/F, IL-17B, IL-17C, IL-17D, IL-17E/IL-25, IL-17F, IL-18, IL-21, IL-22, IL-23, IL-27, IL-29/IFN-λ1, IL-31, IL-33, IP-10, I-TAC, MCP-1, MCP-2, MCP-3, MCP-4, M-CSF, MDC, MIF, MIP-1α, MIP-1β, MIP-3α, MIP-3β, MIP-5, SDF-1α, TARC, TNF-α, TNF-β, TPO, TRAIL, TSLP, VEGF-A, YKL-40 | Human
Multiplex
NEW
U-PLEX Human GM-CSF 384-Well Assay
GM-CSF | Human
Singleplex
NEW
U-PLEX Human Eotaxin-3 384-Well Assay
Eotaxin-3 | Human
Singleplex
NEW
U-PLEX Human IL-13 384-Well Assay
IL-13 | Human
Singleplex
NEW
U-PLEX Human IL-10 384-Well Assay
IL-10 | Human
Singleplex
NEW
U-PLEX Human IL-8 384-Well Assay
IL-8 | Human
Singleplex
NEW
U-PLEX Human IL-6 384-Well Assay
IL-6 | Human
Singleplex
NEW
U-PLEX Human IL-5 384-Well Assay
IL-5 | Human
Singleplex
NEW
U-PLEX Human IL-4 384-Well Assay
IL-4 | Human
Singleplex
NEW
U-PLEX Human MCP-4 384-Well Assay
MCP-4 | Human
Singleplex
NEW
U-PLEX Human MCP-1 384-Well Assay
MCP-1 | Human
Singleplex
NEW
U-PLEX Human I-TAC 384-Well Assay
I-TAC | Human
Singleplex
NEW
U-PLEX Human IP-10 384-Well Assay
IP-10 | Human
Singleplex
NEW
U-PLEX Human TARC 384-Well Assay
TARC | Human
Singleplex
NEW
Human MCP-4 Antibody
MCP-4 | Human
U-PLEX Biomarker Group 3 Human Assays
Human
Multiplex
U-PLEX Custom Biomarker Group 3 (hu) Assays
Human
Multiplex
U-PLEX Biomarker Group 3 Human 21-Plex
A2M, Adiponectin, ApoA1, ApoC3, CA1, Clusterin, Complement C9, Complement factor D, CRP, Cystatin C, DPPIV, Factor VII, ICAM-1, NGAL/LCN2, RBP4, SAA, Serpin A1, SHBG, sTfR-1, VCAM-1, vWF | Human
Multiplex
U-PLEX Human SAA Assay
SAA | Human
Singleplex
U-PLEX Inflammation Combo 1 (hu)
Complement C9, Complement factor D, CRP, ICAM-1, NGAL/LCN2, SAA, VCAM-1 | Human
Multiplex
U-PLEX Vascular Injury Combo 1 (hu)
CRP, Factor VII, ICAM-1, SAA, VCAM-1 | Human
Multiplex
U-PLEX Human SAA Antibody Set
SAA | Human
S-PLEX Proinflammatory Panel 1 (human) Kit
IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-17A, TNF-α | Human
Multiplex
U-PLEX Macrophage M1 Combo 1 (ms)
IL-1β, IL-6, IL-12p70, IL-15, IL-23, IP-10, MCP-1, MIP-1α, TNF-α | Mouse
Multiplex
U-PLEX Macrophage M2 Combo 1 (ms)
IL-4, IL-10, IL-13, MDC, TARC | Mouse
Multiplex
R-PLEX Human Myoglobin Assay
Myoglobin | Human
Singleplex
R-PLEX Human Myoglobin Antibody Set
Myoglobin | Human
S-PLEX Human Eotaxin-3 Kit
Eotaxin-3 | Human
Singleplex
S-PLEX Human IL-13 Kit
IL-13 | Human
Singleplex
S-PLEX Human Eotaxin-3 Antibody Set
Eotaxin-3 | Human
S-PLEX Human IL-13 Antibody Set
IL-13 | Human
S-PLEX NHP IL-5 Kit
IL-5 | Non-human primate
Singleplex
S-PLEX NHP IL-6 Kit
IL-6 | Non-human primate
Singleplex
S-PLEX Human GM-CSF Kit
GM-CSF | Human
Singleplex
S-PLEX Human IL-4 Kit
IL-4 | Human
Singleplex
S-PLEX Human IL-5 Kit
IL-5 | Human
Singleplex
S-PLEX Human IL-6 Kit
IL-6 | Human
Singleplex
S-PLEX Human IL-10 Kit
IL-10 | Human
Singleplex
R-PLEX Mouse SAA Antibody Set
SAA | Mouse
U-PLEX Custom Immuno-Oncology Group 1 (hu) Assays
Human
Multiplex
U-PLEX Immuno-Oncology Group 1 (hu) Assays
Human
Multiplex
U-PLEX Immuno-Oncology Group 1 (hu) 111-Plex
BAFF, BAFF-R/TNFRSF13C, BCMA/TNFRSF17, BDNF, CD20, CD27, CD28, CD40L (soluble), CD276/B7-H3, C-Peptide, CTACK, CTLA-4, ENA-78, Eotaxin, Eotaxin-2, Eotaxin-3, EPO, FGF (basic), FGF-23, FLT3L, Fractalkine, FSH, G-CSF, Ghrelin (active), Ghrelin (total), GIP (active), GIP (inactive), GIP (total), GITR/TNFRSF18, GITRL/TNFSF18, GLP-1 (active), GLP-1 (inactive), GM-CSF, gp130 (soluble), Granzyme A, Granzyme B, GRO-α, HAVCR2/TIM-3, I-309, IFN-α2a, IFN-β, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-2Rα, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17C, IL-17D, IL-17E/IL-25, IL-17F, IL-18, IL-21, IL-22, IL-23, IL-27, IL-29/IFN-λ1, IL-31, IL-33, Insulin, IP-10, I-TAC, LAG3, Leptin, Luteinizing Hormone (LH), MCP-1, MCP-2, MCP-4, M-CSF, MDC, MIF, MIP-1α, MIP-1β, MIP-5, OX40/TNFRSF4, PD1 (epitope 1), PD1 (epitope 2), PD-L1 (epitope 1), PD-L2, PlGF, PP, Proinsulin, PYY (total), RANKL/TNFSF11, SDF-1α, Tie-2, TIGIT, TLR1, TNF-α, TNF-β, TPO, TRAIL, TSLP, VEGF-A, VEGF-D, YKL-40 | Human
Multiplex
U-PLEX Macrophage M1 Combo 1 (hu)
IL-1β, IL-6, IL-12p70, IL-18, IL-23, IP-10, MCP-1, MIP-1α, TNF-α | Human
Multiplex
U-PLEX CAR-T Cell Combo 1 (hu)
GM-CSF, Granzyme A, Granzyme B, IFN-γ, IL-2, TNF-α | Human
Multiplex
U-PLEX Macrophage M2 Combo 1 (hu)
Eotaxin-2, IL-4, IL-10, IL-13, M-CSF, MDC, TARC | Human
Multiplex
U-PLEX Biomarker Group 1 (ms) 29-Plex
IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12p70, IL-15, IL-16, IL-17A, IL-17A/F, IL-17C, IL-17E/IL-25, IL-17F, IL-21, IL-22, IL-23, IL-27p28/IL-30, IL-31, IL-33, IP-10, KC/GRO, MCP-1, MIP-1α, MIP-2, MIP-3α, TNF-α | Mouse
Multiplex
V-PLEX Plus Viral Panel 3 Human Kit
IFN-γ, IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, TNF-α | Human
Multiplex
V-PLEX Plus Viral Panel 3 NHP Kit
IFN-γ, IL-1β, IL-5, IL-6, IL-8, IL-10 | Non-human primate
Multiplex
V-PLEX Viral Panel 3 Human Kit
IFN-γ, IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, TNF-α | Human
Multiplex
V-PLEX Viral Panel 3 NHP Kit
IFN-γ, IL-1β, IL-5, IL-6, IL-8, IL-10 | Non-human primate
Multiplex
U-PLEX Viral Combo 1 (NHP)
G-CSF, GM-CSF, IFN-α2a, IFN-γ, IL-1β, IL-1RA, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12p70, IP-10, MCP-1, MIP-1α, TNF-α, VEGF-A | Non-human primate
Multiplex
U-PLEX Viral Combo 1 (hu)
G-CSF, GM-CSF, IFN-α2a, IFN-β, IFN-γ, IL-1β, IL-1RA, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12p70, IP-10, MCP-1, MIP-1α, TNF-α, VEGF-A | Human
Multiplex
V-PLEX Viral Panel 2 NHP Kit
IFN-γ, IL-1β, IL-6, IL-8, IL-10 | Non-human primate
Multiplex
V-PLEX Viral Panel 2 Human Kit
IFN-γ, IL-1β, IL-4, IL-6, IL-8, IL-10, TNF-α | Human
Multiplex
V-PLEX Viral Panel 1 NHP Kit
IL-1β, IL-6, IL-8 | Non-human primate
Multiplex
V-PLEX Viral Panel 1 Human Kit
IL-1β, IL-6, IL-8, TNF-α | Human
Multiplex
V-PLEX Plus Viral Panel 2 NHP Kit
IFN-γ, IL-1β, IL-6, IL-8, IL-10 | Non-human primate
Multiplex
V-PLEX Plus Viral Panel 2 Human Kit
IFN-γ, IL-1β, IL-4, IL-6, IL-8, IL-10, TNF-α | Human
Multiplex
V-PLEX Plus Viral Panel 1 NHP Kit
IL-1β, IL-6, IL-8 | Non-human primate
Multiplex
V-PLEX Plus Viral Panel 1 Human Kit
IL-1β, IL-6, IL-8, TNF-α | Human
Multiplex
U-PLEX Mouse GM-CSF Assay
GM-CSF | Mouse
Singleplex
U-PLEX Mouse IL-4 Assay
IL-4 | Mouse
Singleplex
U-PLEX Mouse IL-5 Assay
IL-5 | Mouse
Singleplex
U-PLEX Mouse IL-6 Assay
IL-6 | Mouse
Singleplex
U-PLEX Mouse IL-10 Assay
IL-10 | Mouse
Singleplex
U-PLEX Mouse IL-13 Assay
IL-13 | Mouse
Singleplex
U-PLEX Mouse IP-10 Assay
IP-10 | Mouse
Singleplex
U-PLEX Mouse MCP-1 Assay
MCP-1 | Mouse
Singleplex
U-PLEX Mouse RANTES Assay
RANTES | Mouse
Singleplex
U-PLEX Mouse TARC Assay
TARC | Mouse
Singleplex
U-PLEX Mouse TNF-RI Assay
TNF-RI | Mouse
Singleplex
U-PLEX Human I-TAC Assay
I-TAC | Human
Singleplex
U-PLEX Human IL-5 Assay
IL-5 | Human
Singleplex
U-PLEX Human GM-CSF Assay
GM-CSF | Human
Singleplex
U-PLEX Human TARC Assay
TARC | Human
Singleplex
U-PLEX Human MCP-4 Assay
MCP-4 | Human
Singleplex
U-PLEX Human MCP-1 Assay
MCP-1 | Human
Singleplex
U-PLEX Human IP-10 Assay
IP-10 | Human
Singleplex
U-PLEX Human Eotaxin-3 Assay
Eotaxin-3 | Human
Singleplex
U-PLEX Human IL-13 Assay
IL-13 | Human
Singleplex
U-PLEX Human IL-10 Assay
IL-10 | Human
Singleplex
U-PLEX Human IL-8 Assay
IL-8 | Human
Singleplex
U-PLEX Human IL-6 Assay
IL-6 | Human
Singleplex
U-PLEX Human IL-4 Assay
IL-4 | Human
Singleplex
U-PLEX NHP MCP-4 Assay
MCP-4 | Non-human primate
Singleplex
U-PLEX NHP MCP-1 Assay
MCP-1 | Non-human primate
Singleplex
U-PLEX NHP IP-10 Assay
IP-10 | Non-human primate
Singleplex
U-PLEX NHP Eotaxin-3 Assay
Eotaxin-3 | Non-human primate
Singleplex
U-PLEX NHP IL-13 Assay
IL-13 | Non-human primate
Singleplex
U-PLEX NHP IL-10 Assay
IL-10 | Non-human primate
Singleplex
U-PLEX NHP IL-8 Assay
IL-8 | Non-human primate
Singleplex
U-PLEX NHP IL-6 Assay
IL-6 | Non-human primate
Singleplex
U-PLEX NHP IL-4 Assay
IL-4 | Non-human primate
Singleplex
U-PLEX NHP I-TAC Assay
I-TAC | Non-human primate
Singleplex
U-PLEX NHP IL-5 Assay
IL-5 | Non-human primate
Singleplex
U-PLEX NHP GM-CSF Assay
GM-CSF | Non-human primate
Singleplex
U-PLEX NHP TARC Assay
TARC | Non-human primate
Singleplex
Mouse RANTES Tissue Culture Kit
RANTES | Mouse
Singleplex
Product Search
Browse Our Products

By Analytes
By Applications
Search
Customer Service/Orders


Scientific/Technical Support


Instrument Support


Company Headquarters